Outcome of intravenous recombinant tissue plasminogen activator for acute ischemic stroke in patients aged over 80 years

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 16, Iss. 7, 2016-07 ,pp. : 843-849

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors

By Burke James P.   Sander Stephen   Shah Hemal   Zarotsky Victoria   Henk Henry  

Current Medical Research and Opinion, Vol. 26, Iss. 5, 2010-05 ,pp. : 1023-1030

Informa Healthcare

Access to resources Recommend Favorite

Initial experience with the novel patent foramen ovale occlusion device Nit‐Occlud® in patients with stroke or transient ischemic attack

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 7, 2015-06 ,pp. : 1262-1267

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and efficacy of intensive vs. guideline antiplatelet therapy in high‐risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 7, 2015-10 ,pp. : 1159-1165

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of atorvastatin co‐treatment on inhibition of platelet activation by clopidogrel in patients with ischemic stroke

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 10, Iss. 8, 2015-12 ,pp. : E90-E91

John Wiley & Sons Inc

Access to resources Recommend Favorite